Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
AACR Virtual Annual Meeting II featured more than 20 minisymposia sessions during the three-day conference. One such minisymposium focused on Infection and...
Cancer is often described as a disease of old age. However, certain cancers have become increasingly prevalent among younger populations...
Pediatric cancer, while rare, is the leading cause of death by disease among children past infancy in the developed world. The World Health Organization notes...
“It’s going to be a vibrant session,” said session moderator Nada Jabado, MD, PhD. With these words, the first of two sessions featuring the...
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
The Opening Ceremony of the American Association for Cancer Research (AACR) Virtual Annual Meeting II provided a stark reminder that...
This year alone, an estimated 1.8 million people will hear their doctor say they have cancer. The individual impact...
On April 27, cancer researchers, health care professionals, patients, advocates, and policymakers around the world logged on to their...
Immunotherapy research has exploded over the past decade and has led to the approval of seven immune checkpoint inhibitors by the United States Food and Drug Administration (FDA) for the treatment...